The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1524
Drugs for Sexually Transmitted Infections
The full article is available to subscribers Subscriber Login   
TABLES IN THIS ISSUEDrugs of Choice for Some STIsHuman Papillomavirus (HPV) Vaccine

The text and tables that follow include recommendations for management of sexually transmitted infections (STIs) other than HIV and viral hepatitis. Some of the indications and dosages recommended here have not been approved by the FDA.

PARTNER TREATMENT — Management of STIs should include evaluation and treatment of sex partners of infected persons. If possible, partners should be examined and tested for STIs, but in most cases treatment should be initiated regardless of symptoms and without waiting for laboratory test results.

An alternative approach, particularly for heterosexual patients infected with gonorrhea or chlamydia, is to treat sex partners without direct examination or testing, either by prescription ... more       Show References Hide References

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: Drugs for Sexually Transmitted Infections
Article code: 1524a
 Electronic, downloadable article - $25